Phio Pharmaceuticals Corp.
Phio Pharmaceuticals is a clinical-stage siRNA biotechnology company advancing its INTASYL gene silencing technology focused on immuno-oncology therapeutics. Phio's INTASYL compounds are designed to enhance the body's immune cells to more effectively kill cancer cells.
Recent News
Get News by Email
Analyst, journalist, or company stakeholder? Sign up to receive news releases by email for Phio Pharmaceuticals Corp. or all companies belonging to the Biotechnology, Healthcare and Hospitals, Pharmaceuticals, Health industries.
Stock Quote
Financial Market Data copyright © 2023 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.
RSS Feeds
Our last 10 news releases for Phio Pharmaceuticals Corp. in RSS format are available for public consumption. Full text RSS feeds which can be categorized by type and industry are available upon request.